Serum Institute seeks DCGI nod to manufacture Covid-19 vaccine Sputnik V in India

Pune-based Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture Covid-19 vaccine Sputnik V in the country, government sources said on Thursday.

"The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the Covid-19 vaccine, Sputnik V, in India," a source said.

The SII has also sought approval for test analysis and examination. Once the permission comes through, the SII will have to conduct clinical trials. If successful, the SII will become the seventh company to manufacture Sputnik V.

Watch this video to know more.